The wire — 8 November 2026

Sunday, 8 November — no qualifying rounds reached the desk within today's window. Two rounds from earlier in the week — Tuesday 4 November (Supa) and Wednesday 5 November (FluoRok) — arrived after the previous edition closed, and are published today as standalone deal stories, each dated to its real announcement date. No shared theme connects them; this is a timing story, not a thematic one.

FluoRok raises €26.6M Series A — Oxford, United Kingdom. Series A co-led by Orano Ventures Fund / Supernova Invest and Bidra Innovation Ventures, with Oxford Science Enterprises, BGF, GGF, Volta Energy Technologies, the University of Oxford, EverQuest Capital Partners, CPI Enterprises, and WS Investment. The company is an Oxford University spin-out that produces fluorochemicals — including battery electrolyte salts (LiPF6) and pharmaceutical active ingredients — without hydrogen fluoride, using a patented mechanical activation process. The round funds industrialisation: demonstrator facilities for battery electrolyte salts and specialty reagents, team expansion, and next-generation battery products (LiFSI, FEC). Orano's participation via Supernova Invest is strategically notable — the French nuclear fuel group is both a financial investor and a potential industrial customer.

Supa raises £21M (€25M) seed — London, United Kingdom. Co-led by 2150 and OpenOcean, with KOMPAS VC, Actia Partners, and Heartfelt. Founded by Calum Brannan and Alexis Johnson (previously Howsy, acquired by Dexters in 2022), the company acquires established UK residential block management firms, retains their local teams and brands, and automates back-office operations — service charge billing, contractor management, compliance — with AI. The round funds technology development, integration of acquired businesses, further UK acquisitions, and team growth.